Study to Assess the Design of Use of REKOVELLE ® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
Condition: Controlled Ovarian Stimulation Intervention: Drug: Follitropin Delta Sponsor: Ferring Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: ICSI (Intracytoplasmic Sperm Injection) | IVF (in vitro fertilisation) | Research | Study | Women